Top

BMC Cancer

Published in:

Open Access 01-12-2024 | Retraction Note

Retraction Note: Haplotype analysis on correlation between transcription factor 7-like 2 gene polymorphism and breast cancer risk

Authors: Yang Wang, Xiaojuan Men, Yongxue Gu, Huidong Wang, Zhicai Xu

Published in: BMC Cancer | Issue 1/2024

Excerpt

Retraction Note: BMC Cancer 21, 885 (2021) …

Xue P, Cao H, Ma Z, et al. Transcription factor 7-like 2 gene- smoking interaction on the risk of diabetic nephropathy in Chinese Han population. Genes and Environ. 2021;43:26. https://doi.org/10.1186/s41021-021-00194-2.

Title: Retraction Note: Haplotype analysis on correlation between transcription factor 7-like 2 gene polymorphism and breast cancer risk
Authors: Yang Wang
Xiaojuan Men
Yongxue Gu
Huidong Wang
Zhicai Xu
Publication date: 01-12-2024
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-024-12097-w

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial

Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion

PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma

SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

Impact of hepatic inflammation and fibrosis on the recurrence and long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after hepatectomy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer